View Amendment Current Amendment: 2 to Bill 3438 Rep. SPIRES proposes the following Amendment No. 2 to H. 3438 (COUNCIL\VR\3438C002.CC.VR17):

Reference is to Printer's Date 2/15/17-H.

Amend the bill, as and if amended, Section 40-43-86(H)(7) and (8), as contained in SECTION 5, page 14, by striking the items in their entirety and inserting:

/      (7)            Within seven business days following the dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee shall make an entry of the specific biological product provided to the patient, including the name of the biological product and the manufacturer. The communication must be conveyed by making an entry that is electronically accessible to the prescriber through: (i) an interoperable electronic medical records system; (ii) an electronic prescribing technology; (iii) a pharmacy benefit management system; or (iv) a pharmacy record. Entry into an electronic records system as described in this section is presumed to provide notice to the prescriber. Otherwise, the pharmacist shall communicate the biological product dispensed to the prescriber using facsimile, telephone, electronic transmission, or other prevailing means, provided that communication is not required when:
           (a)      there is no federal Food and Drug Administration approved interchangeable biological product for the product prescribed; or
           (b)      a refill prescription is not changed from the product dispensed on the prior filling of the prescription; or
           (c) a biological product is dispensed for inpatient hospital services or is a hospital-administered biological product for outpatients.
     The communication by the dispensing pharmacist or the pharmacist's designee must be monitored by the pharmacist in charge."      /

Renumber sections to conform.
Amend title to conform.